Credit Suisse’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,932
| Closed | -$836K | – | 3051 |
|
|
2023
Q3 | $836K | Buy |
8,932
+132
| +2% | +$12.4K | ﹤0.01% | 2384 |
|
|
2023
Q2 | $785K | Buy |
8,800
+3,800
| +76% | +$339K | ﹤0.01% | 2534 |
|
|
2023
Q1 | $536K | Buy |
5,000
+2,221
| +80% | +$238K | ﹤0.01% | 2693 |
|
|
2022
Q4 | $339K | Buy |
+2,779
| New | +$339K | ﹤0.01% | 2961 |
|
|
2022
Q2 | – | Sell |
-5,900
| Closed | -$692K | – | 3898 |
|
|
2022
Q1 | $692K | Buy |
+5,900
| New | +$692K | ﹤0.01% | 2769 |
|
|
2021
Q4 | – | Sell |
-1,410
| Closed | -$225K | – | 3617 |
|
|
2021
Q3 | $225K | Sell |
1,410
-2,904
| -67% | -$463K | ﹤0.01% | 3347 |
|
|
2021
Q2 | $568K | Buy |
4,314
+1
| +0% | +$132 | ﹤0.01% | 2954 |
|
|
2021
Q1 | $556K | Buy |
4,313
+3
| +0.1% | +$387 | ﹤0.01% | 2893 |
|
|
2020
Q4 | $719K | Sell |
4,310
-89
| -2% | -$14.8K | ﹤0.01% | 2785 |
|
|
2020
Q3 | $680K | Sell |
4,399
-3,591
| -45% | -$555K | ﹤0.01% | 2503 |
|
|
2020
Q2 | $1.18M | Buy |
7,990
+1,121
| +16% | +$166K | ﹤0.01% | 2213 |
|
|
2020
Q1 | $774K | Sell |
6,869
-8,635
| -56% | -$973K | ﹤0.01% | 2286 |
|
|
2019
Q4 | $2.16M | Buy |
15,504
+11,327
| +271% | +$1.58M | ﹤0.01% | 1985 |
|
|
2019
Q3 | $402K | Buy |
+4,177
| New | +$402K | ﹤0.01% | 2910 |
|
|
2016
Q4 | – | Sell |
-15,031
| Closed | -$302K | – | 3715 |
|
|
2016
Q3 | $302K | Sell |
15,031
-999
| -6% | -$20.1K | ﹤0.01% | 3315 |
|
|
2016
Q2 | $212K | Buy |
16,030
+6,014
| +60% | +$79.5K | ﹤0.01% | 3539 |
|
|
2016
Q1 | $186K | Sell |
10,016
-1,204
| -11% | -$22.4K | ﹤0.01% | 3408 |
|
|
2015
Q4 | $205K | Buy |
+11,220
| New | +$205K | ﹤0.01% | 3649 |
|